1,300
Participants
Start Date
February 28, 2009
Primary Completion Date
October 31, 2009
fluID Rapid Influenza Test
The fluID™ Rapid Influenza Test is an in vitro diagnostic assay designed to be used with a reader for the qualitative detection of influenza type A and type B nucleoprotein antigens, and the differentiation of influenza type A subtypes A/H1 and A/H3 antigens associated with the seasonal influenza H1N1 and H3N2, in nasal swabs, nasopharyngeal swabs and nasal wash/aspirate specimens. The test is intended as an aid in the rapid, qualitative diagnosis of influenza type A and type B viral infections in patients symptomatic with influenza-like illness. The fluID™ Rapid Influenza Test is intended for use by a healthcare professional in a laboratory or Point-of-Care (POC).
New York Methodist Hospital, Brooklyn
Forsyth Medical Center, Winston-Salem
University Clinical Research - DeLand, LLC, DeLand
Sinai Grace Hospital, Detroit
Medical College of Wisconsin, Milwaukee
Hennepin County Medical Center, Minneapolis
Washington University at St. Louis, St Louis
Children's Mercy Hospital, Kansas City
Louisiana State University Health Sciences Center, Shreveport
The Family Doctor Research, Shreveport
Granger Medical Clinic, West Valley City
Naval Health Research Center, San Diego
University of Hong Kong, Hong Kong
Lead Sponsor
Centers for Disease Control and Prevention
FED
Nanogen, Inc.
INDUSTRY